Marker Therapeutics Inc (MRKR)

[Gatta-git-it]

Whether 280 are enrolled or at capacity, in my opinion is secondary to this being ph2 and reporting in 2021 rather than this TVIP clinical study having been flushed along with $ 34 million of investors money .... Hope springs anew. Added to MRKR's ph2 work.

If only the company would Press release progress taking place in any and all areas, the share price would be far above where we are at.... below the concrete of the sub basement. Management has never grasped the meaning of being a public company owned by investors.